DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Müller N, Schwarz MJ, Dehning S. et al
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Mol Psychiat 2006;
11 (07) 680-4
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.